---

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

---

Hello Share Twirlers. I’m indulging myself lately by featuring a few of my picks that are doing rather well at the moment. The last one we looked at was IQE, the electronics pioneer, which has been rattling ahead after a rather poor period, when I’m glad to say, I managed to hold my nerve. Now the share seems pretty perky. Today’s success story is Avacta (AVCT).

Follow @ShareProphets

---

---

This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

Search ShareProphets |

---

---

---

Stock market news |

• 

  Nightmare at the Greek Hovel – car won’t start bus to catch: Tom Winnifrith

• 

  Pressure Technologies (#PRES) – Health & Safety charge sentencing hearing postponed until new year “due to a change in judicial availability”

• 

  W Resources (#WRES) – €0.5m revolving credit facility, “in the process of negotiating additional facilities”

• 

  Remote Monitored Systems (#RMS) – “not been able to grow the Geocurve business as previously expected”, “reviewing strategic options”

• 

  OptiBiotix Health (#OPTI) – medical device status and a CE mark for an unflavoured version of SlimBiome Medical

• 

  ContourGlobal (#GLO) – with delay in closing CHP acquisition, now expects FY adj. EBITDA “to be modestly below the bottom end of the previous range”

• 

  Dunelm (#DNLM) – with “sourcing gains and better sell through”, now anticipates FY PBT “higher than our previous expectations”

• 

  Joules (#JOUL) – argues H1 “robust” & “well placed as we enter the important Christmas trading period”

• 

  Time Out (#TMO) – warns, due to Markets expansion, of “modest impact to full year EBITDA”, though argues “encouraged by the early trading” of new sites

• 

  IG Group (#IGG) – expects H1 net trading revenue of c. £250m v. comparative £251m - which included 2 months prior to ESMA product intervention measures

---

---

Complete Coverage

---

Recent Comments |

---